The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
66561237 6656123 7 F 20160913 20080603 20160920 EXP CA-ROCHE-567082 ROCHE 0.00 M Y 0.00000 20160920 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
66561237 6656123 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) U 125085 15 MG/KG Q3W
66561237 6656123 2 SS Glibenclamide GLYBURIDE 1 Unknown U 0 15 MG QD
66561237 6656123 3 SS METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown U 0 2550 MG TABLET QD
66561237 6656123 4 SS DIAZEPAM. DIAZEPAM 1 Unknown U 13263 20 MG QD
66561237 6656123 5 SS DIAZEPAM. DIAZEPAM 1 Unknown U 13263 30 MG QD
66561237 6656123 6 SS DILAUDID HYDROMORPHONE HYDROCHLORIDE 1 Unknown U 0 2 MG QD
66561237 6656123 7 SS DILAUDID HYDROMORPHONE HYDROCHLORIDE 1 Unknown U 0 12 MG QD
66561237 6656123 8 SS LIPITOR ATORVASTATIN CALCIUM 1 Unknown U 0 40 MG TABLET QD
66561237 6656123 9 SS MONOCOR BISOPROLOL FUMARATE 1 Unknown U 0 5 MG TABLET QD
66561237 6656123 10 SS MEDROXYPROGESTERONE ACETATE. MEDROXYPROGESTERONE ACETATE 1 Unknown U 0 100 MG TABLET QD
66561237 6656123 11 SS FLURAZEPAM HYDROCHLORIDE. FLURAZEPAM HYDROCHLORIDE 1 Unknown U 0 30 MG CAPSULE QD
66561237 6656123 12 SS FLURAZEPAM HYDROCHLORIDE. FLURAZEPAM HYDROCHLORIDE 1 Unknown U 0 2 MG CAPSULE QD
66561237 6656123 13 SS HYDROMORPH CONTIN HYDROMORPHONE 1 Unknown U 0 12 MG PROLONGED-RELEASE CAPSULE QD
66561237 6656123 14 C MEDROXYPROGESTERONE ACETATE. MEDROXYPROGESTERONE ACETATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
66561237 6656123 1 Lung neoplasm malignant
66561237 6656123 2 Product used for unknown indication
66561237 6656123 3 Product used for unknown indication
66561237 6656123 4 Product used for unknown indication
66561237 6656123 6 Product used for unknown indication
66561237 6656123 8 Product used for unknown indication
66561237 6656123 9 Product used for unknown indication
66561237 6656123 10 Product used for unknown indication
66561237 6656123 11 Product used for unknown indication
66561237 6656123 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
66561237 6656123 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
66561237 6656123 Asthenia
66561237 6656123 Blood creatinine increased
66561237 6656123 Coma
66561237 6656123 Coma scale abnormal
66561237 6656123 Confusional state
66561237 6656123 Decreased appetite
66561237 6656123 Dehydration
66561237 6656123 Drug ineffective
66561237 6656123 General physical health deterioration
66561237 6656123 Haemoglobin decreased
66561237 6656123 Hypotension
66561237 6656123 Intentional product misuse
66561237 6656123 Mental disorder
66561237 6656123 Mental status changes
66561237 6656123 Pain
66561237 6656123 Toxicity to various agents
66561237 6656123 Treatment noncompliance

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found